Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses (BLEEDING)

Manuel Monreal

Status: Completed

Conditions: COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT04380779

BLEEDING042020

Details and patient eligibility

About

The main objectives are:

• To establish the prevalence of major bleeding in patients treated with higher than recommended thromboprophylaxis doses.
• To identify variables associated to higher risk of bleeding.

Enrollment: 2,430 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients infected with COVID-19 treated with higher than recommended thromboprophylaxis doses.
• Admission to hospital.

Exclusion criteria

• Patients treated with ECMO (Extracorporeal membrane oxygenation).